Aluminum and Iron Overload in Haemodialysis: An International Workshop Held During the XXVth Congress of the European Dialysis and Transplant Association/European Renal Association
Marc E. De Broe, European Dialysis and Transplant Association - European Renal Association. Congress
Hogrefe & Huber Publishers, 1989 - Aluminum - 77 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Increased levels of parathyroid hormone after reduction of aluminium
3 other sections not shown
1,25-dihydroxycholecalciferol 29 Suppl ACKRILL adynamic bone disease aluminaemia alumini aluminium and iron aluminium bone disease aluminium intoxication aluminium overload aluminium toxicity aluminium-induced bone disease aluminium-induced osteomalacia anaemia ANDREss bacteraemia baseline BOELAERT bone biopsy bone formation rate BROE CaCO3 CANNATA chelation chronic renal failure Clin clinical decrease Desferal desferrioxamine desferrioxamine DFO infusion DFO test DFO therapy DFO treatment dialysis patients dose duration of dialysis enterocolitica erythropoietin ferritin Group haemodialysis haemodialysis patients haemoglobin haemosiderosis histological hypoparathyroidism incidence of bacteraemia increased infection iron overload Kidney Int levels of aluminium levels of PTH liver disease LLACH MALLUCHE mEq/ml metabolism mg/kg mmol/l NEBEKER Nephrology normal renal function osteitis fibrosa osteoblast osteoid osteomalacia parathyroid gland parathyroid hormone parathyroidectomy partial responders phosphate binder placebo plasma PTH levels PTH secretion rats receiving DFO serum aluminium levels serum levels SLATOPOLSKY stainable aluminium treated with DFO ug/l uraemia uraemic vitamin vitamin D